-

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against ProAssurance Corporation

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against ProAssurance Corporation (“ProAssurance” or the “Company”) (NYSE: PRA). This investigation concerns whether ProAssurance has violated federal securities laws and/or engaged in other unlawful business practices.

On January 22, 2020, ProAssurance disclosed a $37 million charge to its loss reserves for the fourth quarter of 2019 due to “deteriorating loss experience, driven by a large national healthcare account.”

On this news, the price of ProAssurance shares fell $4.18, or 11.1%, to close at $33.40 on January 23, 2020.

If you acquired ProAssurance securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, and whistleblower litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
(212) 371-6600
investigations@kmllp.com
www.kmllp.com

Kirby McInerney LLP

NYSE:PRA

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
(212) 371-6600
investigations@kmllp.com
www.kmllp.com

Social Media Profiles
More News From Kirby McInerney LLP

ELV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Elevance Health, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it “was not...

ALIT INVESTOR REMINDER: Alight, Inc. Investors Have Until May 15, 2026 To Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Alight, Inc. (“Alight” or the “Company”) (NYSE:ALIT) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until May 15, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead...

LAKE DEADLINE NOTICE: Lakeland Industries, Inc. Investors Encouraged to Contact Kirby McInerney LLP By April 24, 2026

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment in Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ:LAKE), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 24, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaint...
Back to Newsroom